Skip Navigation


Rheumatology Advance Access originally published online on August 3, 2009
Rheumatology 2009 48(10):1328-1329; doi:10.1093/rheumatology/kep224
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
48/10/1328    most recent
kep224v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Marie, I.
Right arrow Articles by Levesque, H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marie, I.
Right arrow Articles by Levesque, H.
Related Collections
Right arrow Osteoarthritis and Cartilage
Right arrow Pharmacology
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Sustained response to infliximab in a patient with relapsing polychondritis with aortic involvement

Isabelle Marie1, Laure Lahaxe1, Séverine Josse1 and Hervé Levesque1

1Département de Médecine Interne, CHU Rouen, Rouen, France

Correspondence to: Isabelle Marie, Département de Médecine Interne, CHU de Rouen, 76031 Rouen Cedex, France. E-mail: isabelle.marie@chu-rouen.fr

The first 10% of the full text of this article appears below.

SIR, Relapsing polychondritis (RP) is a systemic disorder, which is characterized by recurrent inflammation and destruction of cartilage structure [1]. Auricular, nasal, ocular, tracheobronchial and articular impairment are well-recognized manifestations of RP [1]. Aortic involvement is considered to be rare, and usually occurs during the course of the disease [2–3]. We recently observed a new case, which is of particular interest as the patient developed aortic involvement, revealing a recurrence of refractory RP, with favourable outcome after initiation of . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?